Skip to content
thestock.space

On 6 Nov 2026, Nath Bio-Genes (India) was priced at ₹137.43, or 7.5× trailing earnings, against an industry P/E of 14.4×, and the shares are 33% below their 52-week high. Sales and net profit grew 14% and 5.9% a year over 3 years, with ROCE of 8.8% and ROE of 6.3%. Debt is 0.20× equity, and its dividend yield is 1.5%. It is a small-cap company with a market cap of ₹262 Cr, ranked 45th of 72 Agricultural Inputs companies by market cap; the shares fell 21% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹136.60
Day high
₹140.00
Day low
₹135.00
Prev. close
₹136.76
Volume
8K

Health check

2 good · 2 fair · 2 to check
  • ReturnsIn line

    −21.3% over a year, better than 4 of 7 peers.

  • Price tagCheaper

    P/E 7.5 vs industry 14.4.

  • GrowthStrong

    Sales +13.9%, profit +5.9% a year over 3 years.

  • ProfitabilityWeak

    ROCE 8.8% vs peer median 20.9%.

  • Balance sheetFair

    Debt 0.20× equity, interest covered 4.0×.

  • Red flags2 to check

    Return on equity is low at 6.3%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Agricultural Inputs

71 listed peers. Screen the industry

Small cap

₹262 Cr, #45 of 72 in its industry by size.

Moves with the market

Beta 0.84 vs the NIFTY 50: tracks the market closely.

Key metrics

Last 12 months to Jun 2026: sales ₹490 Cr · profit ₹46 Cr
Market cap
₹262 Cr
Small cap
P/E
7.5
Industry 14.4
Price to book
0.45
Peers 4.28
Dividend yield
1.46%
ROE
6.3%
Peers 16.2%
ROCE
8.8%
Peers 20.9%
Debt to equity
0.20
Debt ₹139 Cr
EPS (TTM)
₹18.43
Face value ₹10
OPM (TTM)
10.1%
Net margin 9.3%
Sales growth
+15.8%
Latest quarter vs a year ago
Profit growth
+14.1%
Latest quarter vs a year ago
Price to sales
0.53
EV/EBITDA 5.5

Strengths and risks

Strengths

  • Quarterly sales up 15.8% on a year ago.
  • P/E of 7.5 against an industry P/E of 14.4.

Risks to check

  • Return on equity is low at 6.3%.
  • 33% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; fruit seeds, which includes Rustam +, Rustam, Mukhiya, and Ranjit; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; and seeds for vegetables comprising…

Headquarters
Mumbai
Employees
452
Sector
Basic Materials
ISIN
INE448G01010
Website
nathbiogenes.com

Price range

52 weeks

₹126.15₹204.00

Today

₹135.00₹140.00
Avg volume (3M)
14.6K
1-year return
minus 21.3%
From 52-week high
minus 32.6%

Peers · Agricultural Inputs

Capital-heavy industry columns

Compare with peersScreen the whole industry
Company
COROMANDELCoromandel International1,824.00minus 4.00%53,72434.517.020.9%9.4%0.1110.2%minus 12.4%
FACTFertilisers and Chemicals Travancore750.25minus 1.24%48,547–703.514.2%0.0%2.950.0%minus 15.3%
UPLUPL534.90plus 1.60%45,21423.96.09.9%20.0%0.83−1.2%minus 28.0%
PIINDPI Industries1,735.00minus 1.98%26,32130.013.114.7%24.2%0.031.1%minus 51.9%
SUMICHEMSumitomo Chemical India328.95plus 0.34%16,41929.421.021.0%20.3%0.02−2.6%minus 34.4%
CHAMBLFERTChambal Fertilizers & Chemicals384.70minus 0.91%15,4138.15.721.8%13.7%0.16−9.2%minus 19.4%
BAYERCROPBayer Cropscience3,316.30plus 0.48%14,90420.015.427.9%16.0%0.033.6%minus 31.7%
NATHBIOGENNath Bio-Genes (India)137.43plus 0.49%2627.56.1–10.4%0.2013.9%minus 21.3%
Median of 7 peers–−0.91%26,32126.615.420.9%16.0%0.110.0%−28.0%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
28443.86651.6328
25437.762.447.1293
29.36.13.64.535.2
10.3%13.9%5.4%8.7%10.7%
1.81.91.72.41.9
3.23.74.54.64.3
11111
2.12.12.71.31.2
28.95.52.52.533
2.3%11.7%35.2%100.4%2.2%
28.32.81.6−032.3
14.881.400.84-0.7916.98

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+13.9%
Profit CAGR 3Y
+5.9%
EPS CAGR 3Y
+5.9%
ROE
6.3%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
301333365445
–+10.4%+9.7%+22.0%
249279314392
52.153.451.353.1
17.3%16.0%14.1%11.9%
−0.2−0.13.76.5
9.68.69.915.2
66.53.84
−0.13.4−0.75.9
36.241.640.646.3
3.2%4.7%4.9%10.1%
3539.638.641.6
–+13.2%minus 2.6%+7.9%
18.4320.8520.3121.91

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
19191919
554591625661
105110123139
114160259278
7938801,0261,097
256282286286
22.540.942.942.7
565.85.9
3877.188.575.5
471475603687
7938801,0261,097

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
38.474.617.6−12.6
−2.9−27.4−43.5
−1.7−7.8−2.1−3.8
33.839.411.5−12.9
−2.5−26.8−7.9−3
35.847.89.7−15.6
−3.8−3.8−3.8−3.8

Shareholding pattern

Source: NSE filings
45.6%
promoters
  • Promoters45.60%
  • Public54.40%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202645.60%54.40%0.00
30 Jun 202645.60%54.40%0.00
31 Mar 202645.60%54.40%0.00
31 Dec 202545.60%54.40%0.00
30 Sep 202545.60%54.40%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you